Lv41
680 积分 2022-06-17 加入
“Electric power boost” for CAR-T-cell potency
1小时前
待确认
Targeting YTHDF2 impacts the epitranscriptome and overcomes tumor therapy resistance
1小时前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
1小时前
已完结
Opportunities and limitations of B cell depletion approaches in SLE
2小时前
已完结
Advances in chimeric antigen receptor T cell therapy for autoimmune and autoinflammatory diseases and their complications
2小时前
待确认
Expanding CAR-engineered cell therapies into autoimmune diseases
2小时前
已完结
Synergistic Integration of mRNA-LNP with CAR-Engineered Immune Cells: Pioneering Progress in Immunotherapy
2小时前
已完结
Innovative cell therapies for systemic sclerosis: available evidence and new perspectives
2小时前
已完结
Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis
2小时前
已完结
Expanding genetic diversity and polygenic risk scores application in rheumatic disease studies: a call for inclusive research
10天前
已完结
AtRECQ2, a RecQ-helicase homologue from Arabidopsis thaliana, is able to disrupt different recombinogenic DNA-structures in vitro
Multi-task Learning and Multimodal Fusion for Road Segmentation
皖公网安备34019202002308
